HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel polysaccharide from Lonicerae Japonicae Caulis: Characterization and effects on the function of fibroblast-like synoviocytes.

Abstract
A novel polysaccharide (LJCP-2b) was isolated from Lonicerae Japonicae Caulis, and its structural features were identified by molecular weight distribution, infrared spectrum, monosaccharide composition, methylation analysis and NMR. LJCP-2b was a homogeneous heteropolysaccharide with a molecular weight of 7.0 kDa and composed of glucose, galacturonic acid, galactose, arabinose, rhamnose, xylose, mannose and glucuronic acid. Structural analysis revealed that LJCP-2b was mainly consisted of 1,3,6-β-D-Galp, 1,4-α-D-Glcp, 1,4,6-α-D-Glcp, 1,4-β-D-Galp, 1,2,4-α-L-Rhap and 1,4-α-D-GalpA. In vitro experiments showed that LJCP-2b could affect the function of TNF-α-induced rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS), including weakening cell viability, increasing apoptosis rate, decreased migration number and adhesion capacity, and reduced the levels of IL-6 and IL-1β. These results indicated that LJCP-2b exhibited the activity of inhibiting the hyperproliferation and inflammatory response of RA-FLS, which may be developed for prevention or treatment of RA.
AuthorsZenghao Bi, Yan Zhao, Jinghong Hu, Jie Ding, Pei Yang, Yan Liu, Yuan Lu, Ying Jin, Huimin Tang, Yuhong Liu, Yongqing Zhang
JournalCarbohydrate polymers (Carbohydr Polym) Vol. 292 Pg. 119674 (Sep 15 2022) ISSN: 1879-1344 [Electronic] England
PMID35725209 (Publication Type: Journal Article)
CopyrightCopyright © 2022. Published by Elsevier Ltd.
Chemical References
  • Monosaccharides
  • Polysaccharides
Topics
  • Arthritis, Rheumatoid
  • Fibroblasts
  • Humans
  • Molecular Weight
  • Monosaccharides (analysis)
  • Polysaccharides (chemistry)
  • Synoviocytes

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: